Cyclosporine therapy during the COVID-19 pandemic

doi:10.1016/j.jaad.2020.04.153

. 2020 Aug;83(2):e151-e152.

doi: 10.1016/j.jaad.2020.04.153. Epub 2020 May 4.

Cyclosporine therapy during the COVID-19 pandemic

Lidia Rudnicka¹, Paulina Glowacka², Mohamad Goldust³, Mariusz Sikora², Marta Sar-Pomian², Adriana Rakowska², Zbigniew Samochocki², Malgorzata Olszewska²

Affiliations

¹ Department of Dermatology, Medical University of Warsaw, Warsaw, Poland. Electronic address: lidiarudnicka@gmail.com.
² Department of Dermatology, Medical University of Warsaw, Warsaw, Poland.
³ Department of Dermatology, University of Rome G. Marconi, Rome, Italy; Department of Dermatology, University Medical Center Mainz, Mainz, Germany; Department of Dermatology, University Hospital Basel, Basel, Switzerland.

PMID: 32376422
PMCID: PMC7196541
DOI: 10.1016/j.jaad.2020.04.153

Cyclosporine therapy during the COVID-19 pandemic

Lidia Rudnicka et al. J Am Acad Dermatol. 2020 Aug.

. 2020 Aug;83(2):e151-e152.

doi: 10.1016/j.jaad.2020.04.153. Epub 2020 May 4.

Authors

Lidia Rudnicka¹, Paulina Glowacka², Mohamad Goldust³, Mariusz Sikora², Marta Sar-Pomian², Adriana Rakowska², Zbigniew Samochocki², Malgorzata Olszewska²

Affiliations

¹ Department of Dermatology, Medical University of Warsaw, Warsaw, Poland. Electronic address: lidiarudnicka@gmail.com.
² Department of Dermatology, Medical University of Warsaw, Warsaw, Poland.
³ Department of Dermatology, University of Rome G. Marconi, Rome, Italy; Department of Dermatology, University Medical Center Mainz, Mainz, Germany; Department of Dermatology, University Hospital Basel, Basel, Switzerland.

PMID: 32376422
PMCID: PMC7196541
DOI: 10.1016/j.jaad.2020.04.153

No abstract available

PubMed Disclaimer

Comment in

Using cyclosporine in the COVID era: An emergent need for caution.
Khurana A, Sethia K. Khurana A, et al. J Am Acad Dermatol. 2020 Oct;83(4):e315-e316. doi: 10.1016/j.jaad.2020.06.990. Epub 2020 Jun 27. J Am Acad Dermatol. 2020. PMID: 32603722 Free PMC article. No abstract available.

Cited by

Clinical and Molecular Relationships between COVID-19 and Feline Infectious Peritonitis (FIP).
Sweet AN, André NM, Stout AE, Licitra BN, Whittaker GR. Sweet AN, et al. Viruses. 2022 Feb 26;14(3):481. doi: 10.3390/v14030481. Viruses. 2022. PMID: 35336888 Free PMC article. Review.
Dealing with Corticosteroid and High-Dose Cyclosporine Therapy in a Pyoderma Gangrenosum Patient Contracting a COVID-19 Infection.
May MR, Rübben A, Lennertz A, Vanstreels L, Leijs M. May MR, et al. J Pers Med. 2022 Jan 27;12(2):173. doi: 10.3390/jpm12020173. J Pers Med. 2022. PMID: 35207660 Free PMC article.
Anwendung von Biologika bei allergischen und Typ-2-entzündlichen Erkrankungen in der aktuellen Covid-19-Pandemie^{a, b, c}: Positionspapier des Ärzteverbands Deutscher Allergologen (AeDA)A, der Deutschen Gesellschaft für Allergologie und klinische Immunologie (DGAKI)B, der Gesellschaft für Pädiatrische Allergologie und Umweltmedizin (GPA)C, der Österreichischen Gesellschaft für Allergologie und Immunologie (ÖGAI)D, der Luxemburgischen Gesellschaft für Allergologie und Immunologie (LGAI)E, der Österreichischen Gesellschaft für Pneumologie (ÖGP)F in Kooperation mit der deutschen, österreichischen, und schweizerischen ARIA-GruppeG und der Europäischen Akademie für Allergologie und Klinische Immunologie (EAACI)H.
Klimek L, Pfaar O, Worm M, Eiwegger T, Hagemann J, Ollert M, Untersmayr E, Hoffmann-Sommergruber K, Vultaggio A, Agache I, Bavbek S, Bossios A, Casper I, Chan S, Chatzipetrou A, Vogelberg C, Firinu D, Kauppi P, Kolios A, Kothari A, Matucci A, Palomares O, Szépfalusi Z, Pohl W, Hötzenecker W, Rosenkranz A, Bergmann KC, Bieber T, Buhl R, Buters J, Darsow U, Keil T, Kleine-Tebbe J, Lau S, Maurer M, Merk H, Mösges R, Saloga J, Staubach P, Jappe U, Rabe C, Rabe U, Vogelmeier C, Biedermann T, Jung K, Schlenter W, Ring J, Chaker A, Wehrmann W, Becker S, Freudelsperger L, Mülleneisen N, Nemat K, Czech W, Wrede H, Brehler R, Fuchs T, Tomazic PV, Aberer W, Fink Wagner A, Horak F, Wöhrl S, Niederberger-Leppin V, Pali-Schöll I, Roller-Wirnsberger R, Spranger O, Valenta R, Akdis M, Matricardi PM, Spertini F, Khaltaev N, Michel JP, Nicod L, Schmid-Grendelmeier P, Idzko M, Hamelmann E, Jakob T, Werfel T, Wagenmann M, Taube C, Jensen-Jarolim E, Korn S, Hentges F, Schwarze J, O Mahony L, Knol E, Del Giacco S, Chivato T, Bousquet J, Zuberbier T, Akdis C, Jutel M. Klimek L, et al. Allergo J. 2020;29(4):14-27. doi: 10.1007/s15007-020-2553-y. Epub 2020 Jun 24. Allergo J. 2020. PMID: 32546898 Free PMC article. Review. German. No abstract available.
A deep learning framework for high-throughput mechanism-driven phenotype compound screening and its application to COVID-19 drug repurposing.
Pham TH, Qiu Y, Zeng J, Xie L, Zhang P. Pham TH, et al. Nat Mach Intell. 2021 Mar;3(3):247-257. doi: 10.1038/s42256-020-00285-9. Epub 2021 Feb 1. Nat Mach Intell. 2021. PMID: 33796820 Free PMC article.
Races of small molecule clinical trials for the treatment of COVID-19: An up-to-date comprehensive review.
Hu S, Jiang S, Qi X, Bai R, Ye XY, Xie T. Hu S, et al. Drug Dev Res. 2022 Feb;83(1):16-54. doi: 10.1002/ddr.21895. Epub 2021 Nov 11. Drug Dev Res. 2022. PMID: 34762760 Free PMC article. Review.

See all "Cited by" articles

References

1. Rudnicka L, Gupta M, Kassir M, et al. Priorities for global health community in COVID-19 pandemic [e-pub ahead of print]. Dermatol Ther. 10.1111/dth.13361. Accessed April 28, 2020. - DOI - PMC - PubMed
1. Elston D.M. The coronavirus (COVID-19) epidemic and patient safety. J Am Acad Dermatol. 2020;82(4):819–820. - PMC - PubMed
1. Colombo D., Chimenti S., Grossi P. Prevalence of past and reactivated viral infections and efficacy of cyclosporine a as monotherapy or in combination in patients with psoriatic arthritis—Synergy study: a longitudinal observational study. Biomed Res Int. 2014;2014:941767. - PMC - PubMed
1. Ianevski A., Zusinaite E., Kuivanen S. Novel activities of safe-in-human broad-spectrum antiviral agents. Antiviral Res. 2018;154:174–182. - PMC - PubMed
1. de Wilde A.H., Pham U., Posthuma C.C. Cyclophilins and cyclophilin inhibitors in nidovirus replication. Virology. 2018;522:46–55. - PMC - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information

[1] Rudnicka L, Gupta M, Kassir M, et al. Priorities for global health community in COVID-19 pandemic [e-pub ahead of print]. Dermatol Ther. 10.1111/dth.13361. Accessed April 28, 2020. - DOI - PMC - PubMed

[2] Rudnicka L, Gupta M, Kassir M, et al. Priorities for global health community in COVID-19 pandemic [e-pub ahead of print]. Dermatol Ther. 10.1111/dth.13361. Accessed April 28, 2020. - DOI - PMC - PubMed

[3] Elston D.M. The coronavirus (COVID-19) epidemic and patient safety. J Am Acad Dermatol. 2020;82(4):819–820. - PMC - PubMed

[4] Elston D.M. The coronavirus (COVID-19) epidemic and patient safety. J Am Acad Dermatol. 2020;82(4):819–820. - PMC - PubMed

[5] Colombo D., Chimenti S., Grossi P. Prevalence of past and reactivated viral infections and efficacy of cyclosporine a as monotherapy or in combination in patients with psoriatic arthritis—Synergy study: a longitudinal observational study. Biomed Res Int. 2014;2014:941767. - PMC - PubMed

[6] Colombo D., Chimenti S., Grossi P. Prevalence of past and reactivated viral infections and efficacy of cyclosporine a as monotherapy or in combination in patients with psoriatic arthritis—Synergy study: a longitudinal observational study. Biomed Res Int. 2014;2014:941767. - PMC - PubMed

[7] Ianevski A., Zusinaite E., Kuivanen S. Novel activities of safe-in-human broad-spectrum antiviral agents. Antiviral Res. 2018;154:174–182. - PMC - PubMed

[8] Ianevski A., Zusinaite E., Kuivanen S. Novel activities of safe-in-human broad-spectrum antiviral agents. Antiviral Res. 2018;154:174–182. - PMC - PubMed

[9] de Wilde A.H., Pham U., Posthuma C.C. Cyclophilins and cyclophilin inhibitors in nidovirus replication. Virology. 2018;522:46–55. - PMC - PubMed

[10] de Wilde A.H., Pham U., Posthuma C.C. Cyclophilins and cyclophilin inhibitors in nidovirus replication. Virology. 2018;522:46–55. - PMC - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Cyclosporine therapy during the COVID-19 pandemic

Affiliations

Cyclosporine therapy during the COVID-19 pandemic

Authors

Affiliations

Comment in

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical